How Vaccinated Kids Infect The Non-Vaccinated
by Edward Morgan
With the thousands of mainstream media articles blaming the non-vaccinated for disease outbreaks,
this article will provide a necessary counterbalance by showing the vaccinated can (and do) infect
the non-vaccinated�
A groundbreaking study published in 2013 in the journal Vaccine titled, �Comparison
of virus shedding after lived attenuated and ?pentavalent reassortant rotavirus vaccine,�
referenced the fact that rotavirus vaccines contain live viruses capable of causing infection,
shedding and even transmission to non-vaccinated subjects:
�In fact, transmission of these two rotavirus vaccines or vaccine-reassortment strains to
unvaccinated contacts has been detected [9�13][1], even in the absence of symptoms.�
One of the five studies referenced in the passage above confirming that the vaccinated
can infect the non-vaccinated, �Sibling transmission of vaccine-derived rotavirus
(RotaTeq) associated with rotavirus gastroenteritis,� published in 2009, is the first report in
the literature to identify the transmission of rotavirus vaccine-derived virus to unvaccinated
contacts resulting in symptomatic rotavirus gastroenteritis requiring emergency medical
attention:
�We document here the occurrence of vaccine-derived rotavirus (RotaTeq [Merck and Co, Whitehouse
Station, NJ]) transmission from a vaccinated infant to an older, unvaccinated sibling,
resulting in symptomatic rotavirus gastroenteritis that required emergency department care.�
The study also indicated that two of the five strains of rotavirus within the Rotateq reassorted
to produce a more harmful virus either within the vaccinated infant or within the subsequently
infected unvaccinated sibling:
�Results of our investigation suggest that reassortment between vaccine component strains
of genotypes P7[5]G1 and P1A[8]G6 occurred during replication either in the vaccinated
infant or in the older sibling, raising the possibility that this reassortment may have
increased the virulence of the vaccine-derived virus.�
This phenomenon of Rotateq vaccine strain ?reassortment and subsequent gastoenteritis
infection in vaccine recipients was also observed in a 2012 study in 61 infants.[2]Additionally,
A Nicaraguan study published in 2012 found �the widespread use of the RotaTeq vaccine
has led to the introduction of vaccine genes into circulating human RVs.,� revealing
that the widespread introduction of the vaccine strain has altered the genetic makeup of wild-type
rotavirus that now infects exposed populations.[3]
It has been estimated that between 80-100% of infants shed rotavirus at some point during
25-28 days after vaccination.[4] [5] This reveals that the vaccinated, contrary to widespread
assumptions about the the risks represented by the non-vaccinated, pose a clear risk of
infecting the non-vaccinated, and may be producing the ideal virological conditions for the recombination
of diverse rotavirus strains into vaccine-resistant �super viruses.�
Another case study, reported on in the National Vaccine Information Center�s document on
vaccine viral shedding:
�In 2010, a case report was published in Pediatrics describing a 30-month old healthy
boy who had never received rotavirus vaccine and was infected with vaccine strain rotavirus.
237 He ended up in the emergency room with severe gastroenteritis 10 days after his healthy
two-month old brother was given a dose of Merck�s RotaTeq vaccine.
A stool sample was taken in the emergency room and came back positive for RotaTeq vaccine
derived strains after RT-PCR testing.�
The authors of the case report noted that �transmission of RotaTeq strains to unvaccinated
contacts was not evaluated in the pivotal [pre-licensure] clinical trials.� They added
that both RotaTeq and Rotarix [GlaxoSmithKline Biologicals] vaccines have �the potential
for vaccine-virus transmission to contacts.�
The Rotateq Vaccine: Shot Through with Conflict of Interest
The Rotateq rotavirus vaccine was co-created by Dr. Paul Offit, widely recognized as the
vaccine industry�s leading promoter and apologist.
He is the co-patent holder of one of two live rotavirus vaccines the FDA has approved, and
which the CDC recommends should be administered to infants in 3 doses at ages 2 months, 4
months, and 6 months.
Historically incapable of self-recusal, despite his glaring conflicts of interest, Offit regularly
positions himself as an expert on vaccines, even though he personally gains from presenting
his product (and the CDC�s vaccine schedule as a whole) as safe and effective.
Case in point, in one notorious interview in Parenting magazine he claimed a child can
receive 10,000 vaccines simultaneously without harm (corrected from 100,000 which he suggested
in a previous interview).
The Rotavirus Vaccine Was Dirty from the Start
The first rotavirus vaccine � Rotashield � comprised of four reassorted rhesus-human
rotaviruses was approved in 1999, only to be withdrawn from the market by the FDA nine
months later when it was found to increase the risk for a deadly form of bowel obstruction
known as intussusception in a small subset of highly vulnerable children.[6]
Offit�s Rotateq, which consists of 5 reassorted human-bovine retroviruses (yes, that means
GMO), was believed to be a safer alternative when it was approved by the FDA in 2006, but
newly published research reveals his vaccine suffers from the same exact deadly problems.
Published this month in Vaccine and titled, �Intussusception risk after RotaTeq vaccination:
Evaluation from worldwide spontaneous reporting data using a self-controlled case series approach�,
the study evaluated worldwide reports to the manufacturer of Rotateq up to May 2014, adjusting
for the phenomenon of under-reporting.
The study found that the relative risk of intussception associated with the administration
of Rotateq vaccine increases �3-7 days following vaccination, mainly after the first dose and
marginally after the second and third doses.� The increase in relative risk reached 3.45
fold in the period 3-to-7 days after the first dose, relative to the 15-30-day period control
period.
Another study linking Rotateq to intussusception was published last year in the New England
Journal of Medicine finding approximately 1.5 (95% CI, 0.2 to 3.2) excess cases of intussusception
per 100,000 recipients of the first dose.
Live Vaccines: A Pandora�s Box of Adventitious Viruses
Death or debilitation by bowel obstruction rapidly following Rotateq vaccination is an
acute adverse effect that is unlikely to be overlooked or ignored.
This is why the Vaccine Adverse Effects Reporting System (VAERS): a passive, vaccine post-marketing
surveillance system, has found it to be a significant side effect.
VAERS, however, is believed to capture as little as less than 1% of the actual damage
being done by vaccines, indicating that the extent of harm of the Rotateq is several orders
of magnitude than presently indicated by this report.
Exposure to Rotateq therefore suffers � like many live vaccines � from a darker side,
as far as adverse effects go, which may take months, years, or decades to manifest as part
of the multifactorial smog cloud of modern day toxicities and exposures that eventually
make their way into the bottleneck of a classical diagnosis.
Rotateq, for instance, has been identified to be contaminated with a number of adventitious
viruses; that is to say, viruses that contaminated the live cells and/or biological components
involved in the original vaccine manufacturing process.
These surreptitious agents, unknown to the manufacturers and regulatory agencies that
approved them, infected the vaccines the children given them.
These viruses include:
Porcine Circovirus 1 (PCV-1): In 2010 the FDA suspended the Rotarix vaccine due to the
discovery that it was contaminated with PCV-1 virus, a pig virus, the implications of which
as far as human exposure are still unknown.
Considered less a risk than PCV-2, known to cause a debilitating wasting disease in piglets,
the FDA determined, after review, that PCV-1 does not represent a risk to the millions
of children exposed to it.
Porcine Circovirus 2 (PCV-2): A 2014 study conducted by CDC researchers and published
in Human Vaccines & Immunotherapeutcs titled, �Detection of PCV-2 DNA in stool samples
from infants vaccinated with RotaTeq�,� found for the first time that PCV-2 is shed
in the stool of those vaccinated with Rotateq.
They found �A total of 235 (28.5%) samples from 59 vaccine recipients were positive for
PCV-2 DNA by one or more assays used in this study.� Additionally, �Twenty-two of the
102 vaccine recipients (21.6%) shed RotaTeq� vaccine strain and 10 of these vaccinees (9.8%)
were shedding both PCV DNA and rotavirus vaccine RNA.� In pigs, PCV-2 has been linked to
serious health problems including, �PCV2-associated pneumonia, PCV2-associated enteritis, PCV2-associated
reproductive failure, and Porcine Dermatitis and Nephropathy Syndrome (PDNS).� [source].
In 2010, The FDA ruled, against the precautionary principle, that neither �PCV1 or PCV2 are
known to infect or cause illness in humans, however PCV2 may cause illness in pigs.�
Baboon endogenous strain 7 retrovirus DNA: a 2014 study published inAdvances in Virology
titled, �Screening of Viral Pathogens from Pediatric Ileal Tissue Samples after Vaccination,�
found evidence of contamination with a baboon retrovirus.
Class D Simian Retovirus: a 2010 study published in Journal of Virology revealed that the Rotateq
vaccine contains simian retrovirus DNA (with a 96% match of certainty), which Judy Mikovits,
PhD, confirms may contribute to adverse health effects, regardless of whether it is a self-replicating
virus or not.
Because live vaccines are manufactured through co-culturing cells and biological fluids from
various different species, there is plenty of opportunity for viruses to adapt to, and
recombine to produce infectious agents capable of far greater virulence.
Rotateq is just one of many vaccines in the CDC�s immunization schedule that contain
live viruses capable of infecting those given it, including retroviruses, which have been
called a modern-day Plague owing to the fact that they are capable of infecting the host
as non-HIV acquire immunodeficiency viruses.
For more information read Dr. Judy Mikovits and Kent Heckenlively�s new book Plague
or listen to my interview of Dr. Mikovits on Fearless Parent Radio.
Clearly, given the evidence revealing the potential unintended, adverse effects of the
Rotateq vaccine, especially the potential for it to infect those exposed to it with
adventitious viruses, the implementation of the precautionary principle requires the immediate
suspension of its use until proper toxicological reevaluations can be made.
Anyone who questions the safety of the present CDC immunization schedule should be able to
point to the Rotateq as a perfect example of why the schedule is not at all evidence
based but rather founded in a mythological belief in the safety and effectiveness of
products that have never been proven sound.
Không có nhận xét nào:
Đăng nhận xét